S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH

Documenti analoghi

• IL-18 production upon s100 stimulation is reduced in active sJIA patients compared to sJIA patients in remission and healthy controls
  di: Haar, Nienke Ter, et al.
  Pubblicazione: (2014)
• Combining multiple biomarkers differentiates between active SJIA, SJIA‐MAS and EBV‐HLH
  di: Weaver, L. K.
  Pubblicazione: (2017)
• Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model
  di: Bracaglia, Claudia, et al.
  Pubblicazione: (2014)
• PReS-FINAL-2102: Comparison of sensitivity and specificity of MAS and HLH diagnostic guidelines in 362 children with MAS complicating systemic JIA
  di: Davì, S, et al.
  Pubblicazione: (2013)
• Mutations of familial hemophagocytic lymphohistiocytosis (FHL) related genes and abnormalities of cytotoxicity function tests in patients with macrophage activation syndrome (MAS) occurring in systemic juvenile idiopathic arthritis (sJIA)
  di: Bracaglia, Claudia, et al.
  Pubblicazione: (2014)